Author:
Zedan Magdy Mohamed,Wassefy Mona El,Khashaba Eman Omar,Sallam Hagar,Mabood Suzy Abd El
Abstract
Abstract
Background
Asthma is a chronic inflammatory airway disease characterized by episodic reversible airway obstruction that variably presents with cough, wheezing, shortness of breath, or chest tightness. It is a multigenetic disease, where both genetic and environmental factors have significant roles in pathogenesis. As regard asthma pathogenesis, the chemokine/chemokine receptor system is considered a key point of the immune response in most allergic diseases. This study was done to estimate the prevalence of bronchial asthma among school age children and explore the association between the underlying gene polymorphisms in chemokine receptor 3 (CCR3) and symptom-based clinical asthma phenotypes among a cohort of Egyptian children.
Results
Prevalence of asthma is increasing (20.6%). There are male asthma predominance. Family history of bronchial asthma and allergic diseases are predominant risk factors for asthma development. Sixty asthmatic cases with different clinical phenotypes were compared to 100 healthy controls, results explored that eosinophilic percent and total serum IgE are significantly higher among asthmatic cases versus controls. There are no significant difference regarding eosinophilic percent, serum IgE, and CCR3 T51C gene polymorphism among different clinical asthma phenotypes. There is no significant difference as regards degree of severity of asthma and level of asthma control between CCR3 T51C gene polymorphism.
Conclusion
We conclude the prevalence of bronchial asthma is increasing. Also, eosinophilic percent and serum IgE are elevated in asthma patients, while CCR3 T51C gene polymorphism frequency seemed to be more prevalent among asthmatic subjects however without statistical significance. We recommend a prospective study on larger sample size to validate our results.
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Zedan MM, Laimon WN, Osman AM, Zedan MM (2015) Clinical asthma phenotyping: a trial for bridging gaps in asthma management. World J Clin Pediatr 4(2):13
2. Zedan M, Gamil N, El-Chennawi F, Maysara N, Hafeez HA, Nasef N, Fouda A (2009) Evaluation of different asthma phenotype responses to montelukast versus fluticasone treatment. Pediatric Asthma Allergy Immunol 22(2):63–68
3. Zedan M, Attia G, Zedan MM, Osman A, Abo-Elkheir N, Maysara N, Barakat T, Gamil N (2013) Clinical asthma phenotypes and therapeutic responses. International Scholarly Research Notices 2013. p. 1–7
4. Zedan M, Bakr A, Shouman B, Zaghloul H, Al-Haggar M, Zedan M et al (2014) Single nucleotide polymorphism of IL4C-590T and IL4RA 175V and immunological parameters in Egyptian asthmatics with different clinical phenotypes. J Allergy Ther 5(189):2
5. Skloot GS (2016) Asthma phenotypes and endotypes: a personalized approach to treatment. Curr Opin Pulm Med 22(1):3–9
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献